A new trial to improve treatment for severe lupus is being led by @uclh colleagues.
Using CAR-T therapy to modify the immune system to target unhealthy cells, the trial could reduce, or even remove, the need for lifelong medication for severe lupus. https://t.co/SxuUbeCpo9
📺 In the spotlight: Allan's remarkable recovery with CAR T-cell therapy at UHS. 🏥
This week, former Royal bodyguard, Allan Peters' inspiring journey from 'terminal' cancer to full remission has been making headlines in local media and on national TV.
🧵(1/3) 👇
Strava gives a nice example of why ‘I can still do a round of golf’ is a good marker of fitness. 4.5hrs on one’s feet over 10k distance is no mean feat!
A woman from Hampshire who was diagnosed with cancer and spent weeks in a coma while pregnant has celebrated the birth of her daughter.
https://t.co/rPTiBUm6ke
An incredible story. 👇
Beth faced a diagnosis of Hodgkin Lymphoma complicated by encephalopathy causing her to be unconscious for the first few months of pregnancy.
Last week, Beth visited our @UHS_lymphoma service with the lovely Isabella. 💕🌟
🔗 https://t.co/3fLFkrTrLO
I’m extremely excited to be running the London Marathon next year for a charity close to my heart - Lymphoma Action. I would be grateful if you could spare 5 minutes to clink on this link and read more about the amazing charity and why it’s important to me
https://t.co/IZUGSoY2tK
Obe-cel (AUTO1), a CD19/41BB CAR-T cell therapy, shows fantastic results in relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) in the Phase II FELIX trial. #CART
WELL DONE @drclaireroddie and team
https://t.co/6D0EOSRQdZ
This is such a powerful regimen. 94% 4y PFS is incredible. In places thay use escBEACOPP (& which fund it) this will be the new standard. The question is how far it will extend into ABVD / AVD-N using areas.
US colleagues - will you use it do you think?